Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-04-12 00:00:00 ET · period of report 2023-04-11 · accession 0001104659-23-044662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-12 | 2023-04-11 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +1,500 | 4,747 | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-11 | A | A | 1,500 | $0.00 | 4,747 | D | — | — | (F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022. |